SCIRENT is excited to participate at the TCT Conference from October 23-26, 2023, in San Francisco.
The Transcatheter Cardiovascular Therapeutics (TCT) conference, hosted by the Cardiovascular Research Foundation (CRF), is the world’s premier educational forum for interventional cardiovascular medicine. For over 30 years, TCT has been a beacon of innovation, education, and collaboration in the field.
At SCIRENT, we are dedicated to advancing knowledge in cardiovascular medicine and supporting the development of groundbreaking therapies. As a contract research organization, we specialize in cardiovascular trials, with a specific focus on medical device trials for heart failure and structural heart disease, accounting for 70% of our trial portfolio. That’s why TCT provides an unparalleled platform for us to share our insights, connect with fellow experts, and showcase our contributions to the ever-evolving landscape of interventional cardiology.
We can’t wait to connect with fellow researchers, sponsors, and healthcare professionals at this prestigious event. Together, we’ll continue to make strides in the fight against heart failure.
Stay tuned for updates from TCT 2023. See you in San Francisco!
Book a meeting with our leadership: